Corathers Health Consulting
Dedicated to the Advancement of Medical Innovations

Services for Surgical, Device, Diagnostics and Biotechnology Companies

Featuring our Signature Service: Physician Perception Market Research

  • Physician/Surgeon Perception and Customer Research
  • Product Launch Insight Studies
  • Medical Market Validation Initiatives
  • LuminaryExpress™
  • Medical Advisory Board Facilitation
  • Communication Services

Read more…

Physician/Provider Perception Research

Corathers Health has been perfecting exclusive physician/provider perception research processes that have produced the firm’s signature service. Such exceptional survey and interview capabilities enable Corathers Health to harness vital provider opinions that serve as the foundation for many customized projects.

Read More…

Challenge: Company needed surgeon perceptions in order to better position a specific product and educate their sales force.
Comment: “This is fantastic. You have validated what we thought and offered us great new insight as we move into our national sales meeting.”
Follow-Up Comment: “We hit an all time (national) sales record this past month and believe your work was instrumental in this success.”

Communication Services

Corathers Health can provide medical, surgical, biotechnology and diagnostic device  companies with a variety of unique B2B services.

Read More…

Challenge: Established company with a new diagnostic device needed to identify and be introduced to a specific compliment of industry players around the world.
Comment: “Great contacts!”

Challenge: A global medical device company wanted to identify and communicate with a specific segment of industry players in Asia.
Comment: “This is excellent. Great outcomes!”
Follow-up Comment: “BTW, your work (in Asia) continues to pay off for us!”

Challenge: A technology company launching a new diagnostic device wanted to identify and be introduced to a potential early adaptor (within a specific geographic location in Asia).
Comment: “We are very pleased that they have started to use our device.  Excellent!”

Thursday, February 20